Surmodics, Inc : Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon
Updated safety and performance data for the SWING trial 24-month data will be.
EDEN PRAIRIE, Minn. (BUSINESS WIRE) #InVitroDiagnostic Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2022, and updated its financial outlook for its fis.